UCSF-UCB Tuberculosis Research Advancement Center (TRAC)
UCSF-UCB 结核病研究促进中心 (TRAC)
基本信息
- 批准号:10674698
- 负责人:
- 金额:$ 96.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-02 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAreaAwardBasic ScienceBiomedical ResearchClinicalClinical ResearchClinical SciencesCollaborationsCommunicationCommunitiesComplexConceptionsConsultationsCountryDataDedicationsDevelopmentDiagnosisDiagnosticDisciplineDoctor of PhilosophyEducationEnvironmentEpidemicEquityFacultyFosteringFundingFutureGoalsHealth SciencesHumanIncomeInfrastructureInterdisciplinary StudyInternationalInterventionInvestigationLaboratoriesLaboratory ResearchLeadLeadershipMentorsMentorshipMycobacterium tuberculosisPeer ReviewPeer Review GrantsPopulation SciencesPositioning AttributePreventionProductivityProgram DevelopmentResearchResearch DesignResearch PersonnelResourcesSamplingSan FranciscoScientistServicesSiteSystemTechnical ExpertiseTechnologyTrainingTraining ProgramsTuberculosisUnited States National Institutes of HealthVaccinescareercareer developmentcohortcommunity centercommunity engagementdata managementdesignexperienceexperimental studyflexibilityforginghuman subjectimprovedinnovationinterdisciplinary collaborationinternational partnershipmembermobile computingmultidisciplinarynext generationoperationpathogenpreventprogramssuccesstooltuberculosis treatmentvoucher
项目摘要
PROJECT SUMMARY
The overall goal of the proposed UC San Francisco – UC Berkeley Tuberculosis Research Advancement Center
(UCSF-UCB TRAC) is to accelerate the pace of discoveries that improve our understanding of tuberculosis (TB)
and lead directly to new tools for diagnosis, prevention, and treatment of TB. Addressing the complex problems
of the current heavy burden and persistence of the TB epidemic requires partnerships across disciplines;
mobilization of technology for identification, intervention, and prevention; and mentoring of future scientists and
clinicians. The UCSF-UCB TRAC is uniquely positioned to address these challenges for radically new
treatments, better diagnostics and an effective vaccine. UCSF and UCB represent a major hub of NIH-funded
TB research with many labs across the wide spectrum of disciplines, and the UCSF-UCB TRAC will fill a critical
gap in a prominent clinical and basic science research environment. Our proposed UCSF-UCB TRAC will allow
us to, (1) attract and support New Investigators (NI) in the TB field by providing pilot awards, training, longitudinal
mentorship and other key services and resources; and (2) attract and enable non-TB investigators to enter the
field by providing awards, key resources and opportunities for multidisciplinary collaboration that support new
directions in TB research. Further, our Center tightly integrates 4 cores: 1) an Administrative Core to provide
leadership, infrastructure, administrative and communication support, advice and oversight to coordinate all
UCSF-UCB TRAC operations; 2) a Basic Science Core to lower traditional barriers experienced by investigators
to facilitate innovative, multidisciplinary, fundamental TB research through a suite of cutting edge technologies
accessible in BSL-3/ABSL-3 facilities; 3) a Clinical Science Core to augment existing UCSF and UCB resources
to accelerate clinical research by engaging new investigators and reducing the barrier to conducting high-quality,
innovating clinical research; and 4) a Developmental Core to attract and develop scientific leaders in TB research
via a platform of services to support a continuum of ideas to independence in TB research, offering mentoring,
professional development, proposal support, and research funding. The UCSF-UCB TRAC will add value to the
robust research enterprises of UCSF and UC Berkeley by bridging traditional silos between fundamental and
clinical TB and by providing a nucleating factor for coordinated TB research resources and collaboration at the
two campuses and at affiliated international research sites.
项目摘要
拟议的UC旧金山UC - UC Berkeley结核病研究进步中心的总体目标
(UCSF-UCB TRAC)是为了加速发现我们对结核病(TB)的发现空间
直接导致新工具用于诊断,预防和治疗结核病。解决复杂问题
目前,结核病流行的重烧和持久性需要跨学科的伙伴关系;
动员技术以识别,干预和预防;以及未来科学家的心理
临床医生。 UCSF-UCB TRAC的独特位置可以解决根本新的挑战
治疗,更好的诊断和有效的疫苗。 UCSF和UCB代表了NIH资助的主要枢纽
与广泛学科的许多实验室有关的结核病研究,UCSF-UCB TRAC将填补关键
在著名的临床和基础科学研究环境中的差距。我们提议的UCSF-UCB TRAC将允许
我们要(1)通过提供试点奖,培训,纵向,吸引并支持结核病领域的新调查员(NI)
指导和其他关键服务和资源; (2)吸引并使非TB调查人员进入
通过提供奖励,关键资源和跨学科合作的机会来支持新的领域
结核病研究方向。此外,我们的中心紧密整合了4个核心:1)提供的行政核心
领导,基础设施,行政和沟通支持,建议和监督以协调所有
UCSF-UCB TRAC操作; 2)降低调查人员经历的传统障碍的基本科学核心
通过一系列尖端技术促进创新的,多学科的基本结核病研究
可在BSL-3/ABSL-3设施中访问; 3)增加现有UCSF和UCB资源的临床科学核心
通过吸引新的研究人员并减少进行高质量的障碍来加速临床研究
创新临床研究; 4)一个发育核心,吸引和培养结核病研究中的科学领导者
通过服务平台来支持结核病研究中独立的思想的连续性,提供心理,
专业发展,建议支持和研究资金。 UCSF-UCB TRAC将为
通过在基本和
临床结核病并通过为协调结核病研究资源和协作的成核因素
两个校园和会员国际研究地点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFERY S COX其他文献
JEFFERY S COX的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFERY S COX', 18)}}的其他基金
UCSF-UCB Tuberculosis Research Advancement Center (TRAC)
UCSF-UCB 结核病研究促进中心 (TRAC)
- 批准号:
10431539 - 财政年份:2022
- 资助金额:
$ 96.85万 - 项目类别:
M. tuberculosis strain-dependent interactions with host cells
结核分枝杆菌与宿主细胞的菌株依赖性相互作用
- 批准号:
10459539 - 财政年份:2021
- 资助金额:
$ 96.85万 - 项目类别:
M. tuberculosis strain-dependent interactions with host cells
结核分枝杆菌与宿主细胞的菌株依赖性相互作用
- 批准号:
10653910 - 财政年份:2021
- 资助金额:
$ 96.85万 - 项目类别:
M. tuberculosis strain-dependent interactions with host cells
结核分枝杆菌与宿主细胞的菌株依赖性相互作用
- 批准号:
10271172 - 财政年份:2021
- 资助金额:
$ 96.85万 - 项目类别:
PROJECT 1: Identification of host and bacterial pathways that control tuberculosis pathogenesis in humans
项目 1:鉴定控制人类结核病发病机制的宿主和细菌途径
- 批准号:
10550001 - 财政年份:2018
- 资助金额:
$ 96.85万 - 项目类别:
Research Training at the Confluence of Infectious and Non-Communicable Diseases in India
印度传染病和非传染性疾病交汇处的研究培训
- 批准号:
10361555 - 财政年份:2017
- 资助金额:
$ 96.85万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 96.85万 - 项目类别:
MAIT cells in lupus skin disease and photosensitivity
MAIT 细胞在狼疮皮肤病和光敏性中的作用
- 批准号:
10556664 - 财政年份:2023
- 资助金额:
$ 96.85万 - 项目类别:
Promoting Caregiver Implementation of an Effective Early Learning Intervention
促进看护者实施有效的早期学习干预
- 批准号:
10636211 - 财政年份:2023
- 资助金额:
$ 96.85万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 96.85万 - 项目类别:
NeuroMAP Phase II - Recruitment and Assessment Core
NeuroMAP 第二阶段 - 招募和评估核心
- 批准号:
10711136 - 财政年份:2023
- 资助金额:
$ 96.85万 - 项目类别: